- Clinical Use of New Insulins and New Insulin Delivery Systems
-
Lim TS, Ko SH
- KMID: 2173850
- J Korean Diabetes.
- 2015 Dec;16(4):242-251.
- doi: 10.4093/jkd.2015.16.4.242
Insulin plays an important role in the treatment of diabetes. Since it was discovered in the early 1920s, major advances have been made in the medical use of insulin. However,... -
- CITED
-
- Close
- SHARE
-
- Close
- Therapeutic Efficacy of Combined Therapy with Once Daily Insulin Glargine and Once Daily Glimepiride in Korean Type 2 Diabetic Patients
-
Park JY, Kim HJ, Koo BK, Kim HJ, Pak GS, Han KA, Min KW, Kim EJ
- KMID: 2331801
- J Korean Diabetes Assoc.
- 2007 Sep;31(5):391-401.
BACKGROUND: Once daily injection and 24 hour lasting glucose lowering effect of insulin glargine had recently changed a perception about the early insulin treatment of type 2 diabetic patients. This... -
- CITED
-
- Close
- SHARE
-
- Close
- Application of an Insulin Analogue in Six Hypoglycemia-Prone Hemodialysis Patients with Type 2 Diabetes
-
Kim GE, Hong SB, Han JY, Jang JH, Yang DH, Lee SW, Song JH
- KMID: 2263415
- Korean J Med.
- 2012 Nov;83(5):647-653.
Day-to-day insulin requirements often change due to subtle variations in insulin metabolism in patients with type 2 diabetes undergoing hemodialysis. In such cases, intra-hemodialysis hypoglycemia frequently occurs and is a... -
- CITED
-
- Close
- SHARE
-
- Close
- Practical Focus on American Diabetes Association/European Association for the Study of Diabetes Consensus Algorithm in Patients with Type 2 Diabetes Mellitus: Timely Insulin Initiation and Titration (Iran-AFECT)
-
Khamseh ME, Yousefzadeh G, Banazadeh , Ghareh S
- KMID: 2368527
- Diabetes Metab J.
- 2017 Feb;41(1):31-37.
- doi: 10.4093/dmj.2017.41.1.31
BACKGROUND: The aim of this study was to evaluate the safety and effectiveness of insulin glargine in a large population from a variety of clinical care in Iranian people with... -
- CITED
-
- Close
- SHARE
-
- Close
- Short-term Therapeutic Efficacy of Different Oral Hypoglycemic Agents Combined with Once Daily Insulin Glargine in Type 2 Diabetic Subjects with Failure of Sulfonylurea and Metformin Combination
-
Hong SI, Kim HJ, Bae JM, Song SO, Park KS, Jeon BS, Hwang SD, Choi JY, Kim JH, Kwon HJ, Choi JS, Woo ML, Cho JH, Won YJ
- KMID: 2222521
- J Korean Diabetes Assoc.
- 2007 Jul;31(4):336-342.
- doi: 10.4093/jkda.2007.31.4.336
Backgroud: Although the extended duration of action of insulin glargine supports a convenient once daily injection, the combination with other short acting insulins or oral hypoglycemic agents is required to... -
- CITED
-
- Close
- SHARE
-
- Close
- Exenatide versus Insulin Lispro Added to Basal Insulin in a Subgroup of Korean Patients with Type 2 Diabetes Mellitus
-
Yoon KH, Hardy E, Han J
- KMID: 2368531
- Diabetes Metab J.
- 2017 Feb;41(1):69-74.
- doi: 10.4093/dmj.2017.41.1.69
BACKGROUND: The prevalence of type 2 diabetes mellitus (T2DM) and obesity is increasing in Korea. Clinical studies in patients with T2DM have shown that combining the glucagon-like peptide-1 receptor agonist... -
- CITED
-
- Close
- SHARE
-
- Close
- Glycemic Effects of Once-a-Day Rapid-Acting Insulin Analogue Addition on a Basal Insulin Analogue in Korean Subjects with Poorly Controlled Type 2 Diabetes Mellitus
-
Choe EY, Lee YH, Lee BW, Kang ES, Cha BS, Lee HC
- KMID: 2281404
- Diabetes Metab J.
- 2012 Jun;36(3):230-236.
- doi: 10.4093/dmj.2012.36.3.230
BACKGROUND: The present study investigates the efficacy in glycemic control by adding once-a-day glulisine to glargine as a basal plus regimen and factors influencing glycemic control with the basal plus... -
- CITED
-
- Close
- SHARE
-
- Close
- Predetermined Anti-Diabetic Drug Regimen Adjustments during Ramadan Fasting: An Observational Study of Safety
-
Beano AM, Zmaili MA, Gheith ZH, Naser AM, Momani MS, Yousef AM, Zayed AA
- KMID: 2384086
- Endocrinol Metab.
- 2017 Jun;32(2):265-273.
- doi: 10.3803/EnM.2017.32.2.265
BACKGROUND: Many Muslim type 2 diabetes mellitus (T2DM) patients choose to fast the month of Ramadan despite the possible adverse health effects brought about by the change in dietary habits,... -
- CITED
-
- Close
- SHARE
-
- Close
- Determining the Factors that Influence the Insulin Requirements in Type 2 Diabetic Patients
-
Chung JO, Cho DH, Chung DJ, Chung MY
- KMID: 2169016
- Endocrinol Metab.
- 2010 Jun;25(2):110-118.
- doi: 10.3803/EnM.2010.25.2.110
BACKGROUND: The initial insulin dose is often determined by clinical experience or with a formula using the body weight. However, it may be difficult to determine the initial insulin dose... -
- CITED
-
- Close
- SHARE
-
- Close
- Effectiveness and Safety of Adding Basal Insulin Glargine in Patients with Type 2 Diabetes Mellitus Exhibiting Inadequate Response to Metformin and DPP-4 Inhibitors with or without Sulfonylurea
-
Kang YM, Jung CH, Lee SH, Kim SW, Song KH, Kim SG, Kim JH, Cho YM, Park TS, Ku BJ, Koh G, Kim DM, Lee BW, Park JY
- KMID: 2455667
- Diabetes Metab J.
- 2019 Aug;43(4):432-446.
- doi: 10.4093/dmj.2018.0092
BACKGROUND: We aimed to investigate the effectiveness and safety of adding basal insulin to initiating dipeptidyl peptidase-4 (DPP-4) inhibitor and metformin and/or sulfonylurea (SU) in achieving the target glycosylated hemoglobin... -
- CITED
-
- Close
- SHARE
-
- Close
- The effect of Lantus on glycemic control in children and adolescents with type 1 diabetes mellitus
-
Rhie YJ, Chae HW, Kim HS, Kim DH
- KMID: 2278487
- Korean J Pediatr.
- 2007 Jun;50(6):565-569.
- doi: 10.3345/kjp.2007.50.6.565
PURPOSE: With a duration of action of approximately 24 hours and peakless levels, Lantus is a more physiologic basal insulin analogue compared with NPH. The aim of this study was... -
- CITED
-
- Close
- SHARE
-
- Close
